This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated RHEB Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-RHEB WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~20.5 kDa | |
| Gel | 12–15% (standard starting point) | |
| Positive control | Appendix (IHC candidate; verify WB) +4 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | Phosphorylated + Methylated | |
| Caveat | Phosphorylation-state controls | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 1 isoform(s) |
The A00827-1 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | mouse brain cell lysate (catalog A00827-1) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Short semi-dry transfer; verify retention (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A00827-1 · (A) 1, (B) 2, and (C) 4 μg/mL (catalog A00827-1) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
Rheb is predicted at 20.5 kDa; propeptide cleavage and listed modifications are possible influences, but their effects on visible migration are not established.
| Band near 20.5 kDa | Consistent with the predicted mass of full-length Rheb; confirm identity with antibody controls |
| Band slightly below 20.5 kDa | Could reflect cleavage of the annotated 182–184 propeptide, though a visible difference is not established |
| Weak band in soluble lysate | Consistent with Rheb association with cytoplasmic membrane surfaces |
| Band well above 20.5 kDa | Its identity and migration require verification; the supplied features do not establish this shift |
| Predicted full-length mass | Provides a 20.5 kDa reference, not a measured migration position |
| Propeptide at residues 182–184 | Cleavage would make the mature protein slightly smaller; a resolvable shift is not established |
| Phosphoserine at residue 130 | No apparent size shift is established by the supplied evidence |
| Cysteine methyl ester at residue 181 | No apparent size shift is established by the supplied evidence |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Membrane-associated Rheb may be depleted from a soluble lysate | Check the membrane-containing fraction and a sample preparation control |
| Band higher than expected | The supplied features do not establish the cause of a large upward shift | Confirm identity with an independent Rheb antibody or RHEB depletion control |
| Band lower than expected | Cleavage of residues 182–184 may cause only a small size change; a larger difference is unexplained | Confirm identity and check sample handling for proteolysis |
| Multiple bands | One isoform is listed, and distinct migration states are not established | Compare bands using RHEB depletion or an independent antibody |
| Weak or no signal | Membrane-associated Rheb may be poorly recovered | Check extraction and loading of the membrane-containing fraction |
| Fragments below expected size | Proteolysis during sample handling is possible; the annotated propeptide does not explain large fragments | Prepare fresh lysate with protease inhibitors and confirm band identity |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Appendix | glandular cells | Medium | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | Medium | Protein (IHC) | HPA → |
| Breast | glandular cells | Medium | Protein (IHC) | HPA → |
| Cerebral cortex | neuropil | Medium | Protein (IHC) | HPA → |
| Cervix | squamous epithelial cells | Medium | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | Not detected | Protein (IHC) | HPA → |
| Fallopian tube | glandular cells | Not detected | Protein (IHC) | HPA → |
| Ovary | follicle cells | Not detected | Protein (IHC) | HPA → |
| Smooth muscle | smooth muscle cells | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for RHEB, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
Four the supplier anti-RHEB antibodies have Western blot images showing mouse brain, rat heart, Raji, or A431 lysates. Each image documents a specific sample and condition; the supplied evidence does not establish performance across every listed species or tissue.
Which to pick: For mouse brain lysate, consider A00827-1; for rat heart lysate, A00827. For human Raji or A431 lysate, consider M00827-1 or A00827-2, respectively. All four have WB images; match your sample to the shown context and listed reactivity.